Avaí Bio adopts new corporate name in Nevada

AVAI Bio, Inc., formerly Avant Technologies, Inc., reported a corporate name change.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

AVAI Bio, Inc., formerly Avant Technologies, Inc., reported a corporate name change. On February 3, 2026, the Nevada corporation filed a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State to change its name to Avaí Bio, Inc. The company’s ticker symbol will remain “AVAI.”

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What corporate change did AVAI disclose in this 8-K filing?

AVAI disclosed that Avant Technologies, Inc. changed its corporate name to Avaí Bio, Inc. The change became effective when a Certificate of Amendment to the Articles of Incorporation was filed with the Nevada Secretary of State on February 3, 2026.

Will Avant Technologies, Inc. change its stock ticker after becoming Avaí Bio, Inc. (AVAI)?

No, the stock ticker will remain “AVAI” after the name change to Avaí Bio, Inc. The 8-K specifies that only the corporate name of the Nevada company changed; the trading symbol identified for the company will continue to be AVAI going forward.

When was the name change from Avant Technologies to Avaí Bio, Inc. made effective?

The name change became effective on February 3, 2026. On that date, Avant Technologies, Inc., a Nevada corporation, filed a Certificate of Amendment of its Articles of Incorporation with the Nevada Secretary of State to officially adopt the new name Avaí Bio, Inc.

What exhibit is included with AVAI’s 8-K regarding the name change?

The filing includes Exhibit 10.1, which is the Certificate of Amendment to the Articles of Incorporation of Avant Technologies, Inc. This certificate was filed with the State of Nevada on February 3, 2026 to effect the company’s name change to Avaí Bio, Inc.

Who signed the AVAI 8-K reporting the name change to Avaí Bio, Inc.?

The report was signed on behalf of Avant Technologies, Inc. by Vitalis Racius. He is identified as the company’s Chief Financial Officer, Director, and Treasurer, and signed the document dated February 9, 2026 in that capacity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/09/2026 - 08:52 AM EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 3, 2026

AVAI BIO, INC.

(Exact name of registrant as specified in its charter)

AVANT TECHNOLOGIES INC.

(Former name or former address, if changed since last report.)

Nevada

(State or other jurisdiction of incorporation or organization)

333-225433

(Commission File Number)

38-4053064

(I.R.S. Employer Identification Number)

c/o Eastbiz.com, Inc 5348 Vegas Drive, Las Vegas, NV 89108

(Address and telephone number of principal executive offices)

(Issuer’s telephone number)

(866) 533-0065

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act: Not applicable.

Title of each class		Trading Symbol		Name of each exchange on which registered
Not applicable

Item 8.01 Other Events.

On February 3, 2026, Avant Technologies, Inc., a Nevada corporation (the “Company”) filed a Certificate of Amendment of its Articles of Incorporation with the Secretary of State of the State of Nevada to change the name of the Company to Avaí Bio, Inc. The Company’s ticker symbol will remain “AVAI.”

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	Description
10.1	Certificate of Amendment to the Articles of Incorporation of Avant Technologies, Inc. (filed with the State of Nevada on February 3, 2026).

SIGNATURES

In accordance with the requirements of the Securities Act of 1933, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



Dated: February 9, 2026	AVANT TECHNOLOGIES INC.

	By:	/s/	Vitalis Racius
		Name:	Vitalis Racius
		Title:	Chief Financial Officer, Director & Treasurer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Agreements & Contracts

EX-10.1 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF AVANT TECHNOLOGIES, 1.0 KB